Clinical Research Directory
Browse clinical research sites, groups, and studies.
To Describe How Well Vinorelbine Given Orally Works in Patients With a Breast Cancer After 2 Years of Treatment
Sponsor: Pierre Fabre Medicament
Summary
This study looks at how well oral vinorelbine works in treating advanced breast cancer. It looks at women who have already had this treatment or are currently having it.
Official title: Advanced Breast Cancer Patients Treated With Oral Vinorelbine: a Prospective and Retrospective, Observational Study - VINOREAL
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
368
Start Date
2024-09-10
Completion Date
2028-02
Last Updated
2025-07-24
Healthy Volunteers
No
Conditions
Interventions
Vinorelbine Tartrate Oral
The recommended dosage for oral vinorelbine is 60 mg/m² of body surface area (BSA) administered once weekly for the first three weeks, followed by 80 mg/m² of BSA for the following weekly administration.
Locations (3)
Centre Hospitalo-Universitaire Mustapha, Hopital Mustapha, Place du 1er Mai 1945, Sidi M'Hamed
Algiers, Algeria
Tianjing Medical University Cancer Institute & Hospital
Tianjin, Tianjin Municipality, China
Azienda Ospedaliera San Gerardo U.O. Oncologia Medica
Monza, Italy